Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC77663 | PB-22 6-Hydroxyisoquinoline isomer |
PB-22 6-Hydroxyisoquinoline isomer is a structural isomer of PB-22. PB-22 is a cannabinoid.
More description
|
![]() |
DC77662 | PB-22 5-Hydroxyquinoline isomer |
PB-22 5-hydroxyquinoline isomer is a structural isomer of PB-22. PB-22 is a cannabinoid.
More description
|
![]() |
DC77661 | PB-22 5-Hydroxyisoquinoline isomer |
PB-22 5-Hydroxyisoquinoline isomer is a structural isomer of PB-22. PB-22 is a cannabinoid.
More description
|
![]() |
DC77660 | PB01 |
PB01 is a DPP-4 inhibitor with an IC50 of 15.66 nM. It effectively inhibits high glucose-induced ROS production and mitochondrial superoxide formation while significantly reducing cellular DPP-4 expression. PB01 can also significantly lower blood glucose levels in diabetic mice. Additionally, PB01 demonstrates good safety, exhibiting almost no cytotoxicity at a concentration of 100 μM. PB01 holds potential for research in the field of diabetes.
More description
|
![]() |
DC77659 | Pasodacigib |
DGKα-IN-9 (example 298) is an inhibitor of DGKα.
More description
|
![]() |
DC77658 | Panepophenanthrin |
Panepophenanthrin is a compound that can be isolated from the mushroom strain, Panus rudis Fr. IFO 8994. Panepophenanthrin is a ubiquitin-activating enzyme inhibitor.
More description
|
![]() |
DC77657 | PAF C-16 carboxylic acid |
PAF C-16 carboxylic acid (Acetyl-CPGPC) is a phospholipid that possesses haptenic activity causing production of antibodies reactive with platelet-activating factor (PAF).
More description
|
![]() |
DC77656 | Paeoniflorin-6′-O-benzene sulfonate |
Paeoniflorin-6′-O-benzene sulfonate (CP-25) is the inhibitor for G protein-coupled receptor kinase 2 (GRK2) that inhibits the translocation of GRK2 to the cell membrane, inhibits JAK1/STAT3 signaling pathway. Paeoniflorin-6′-O-benzene sulfonate inhibits IL-17A/CXCL2-induced proliferation of HaCaT. Paeoniflorin-6′-O-benzene sulfonate reduces the levels of inflammatory factors and chemokines such as IL-17A, IL-17F, IFN-γ, TNF-α, IL-22, IL-23, CXCL2, CXCL3 and CXCL9, alleviates Imiquimod-induced psoriasis in mouse model.
More description
|
![]() |
DC77655 | P5SA-2 |
P5SA-2 is a selective allosteric activator of PPP5C. P5SA-2 exerts its effects by modulating the phosphatase domain of PPP5C and can increase PPP5C activity by 3.2-fold at 100 μM with an apparent affinity constant of 7.8 μM. P5SA-2 can be used in cancer and Alzheimer's disease research.
More description
|
![]() |
DC77654 | p53 Stabilizer 2 |
p53 Stabilizer 2 (Compound 17a16) is a p53 stabilizer. p53 Stabilizer 2 induces S-phase arrest and apoptosis in both p53-proficient and p53-deficient cancer cells. p53 Stabilizer 2 induces mitochondrial stress and activates two checkpoint pathways: NA-PKcs-dependent p53 stabilization and ATR-Chk1 axis activation. p53 Stabilizer 2 inhibits tumor growth in p53-deficient xenograft model.
More description
|
![]() |
DC77653 | P162-0948 |
P162-0948 is a selective CDK8 inhibitor with an IC50 value of 50.4 nM. P162-0948 reduces cell migration and protein expression of EMT-related proteins in A549 human alveolar epithelial cell lines. P162-0948 reduces phosphorylation of Smad, which suggests disruption of the TGF-β/Smad signaling pathway. P162-0948 is promising for research of pulmonary fibrosis.
More description
|
![]() |
DC77652 | OPB-3206 |
OPB-3206 is a selective matrix metalloproteinase (MMP) inhibitor. OPB-3206 inhibits interstitial collagenase, gelatinase A (MMP-2), gelatinase B (MMP-9) and stromelysin with IC50 values of 7×10-7 M, 5×10-6 M, 5×10-7 M and 2×10-6 M, respectively. OPB-3206 reversibly binds to the zinc-binding region of MMPs, preventing the activation of MMP-9 and reducing extracellular matrix degradation to inhibit tumor lung metastasis. OPB-3206 is promising for research of lung metastasis of osteosarcoma.
More description
|
![]() |
DC77651 | Ontunisertib |
Ontunisertib (Example 26) is an inhibitor of TGFβ receptor I/ALK5 (TGFβRI/ALK5), with IC50 values ranging from 100 to 500 nM for TGFβRI and an IC50 value of ≤100 nM for ALK5. Ontunisertib can be used in research on gastrointestinal diseases, as well as diseases and cancers related to fibrotic conditions in the skin and eyes.
More description
|
![]() |
DC77650 | OncoFAP-GlyPro-MMAF |
OncoFAP-GlyPro-MMAF is a Drug-Linker Conjugate for ADC with potent antitumor activity. OncoFAP-GlyPro-MMAF consists of Monomethylauristatin F analog and TRPM7 inhibitor (IC50 = 1.081 μM) with multimodal anti-inflammatory effects and without targeting S1P receptors. AAL-149 can be utilized in anti-inflammatory research.
More description
|
![]() |
DC77649 | OICR-8268-acrylic acid |
OICR-8268-acrylic acid is a ligand for E3 ubiquitin ligase. OICR-8268-acrylic acid can be connected to the ligand for protein by a linker to form OICR41114.
More description
|
![]() |
DC77648 | OICR11029 |
OICR11029 is a highly efficient probe for Bcl-6.
More description
|
![]() |
DC77647 | Ogerin analogue 1 |
Ogerin analogue 1 (compound 20) is a structural analog of Ogerin. Olanzapine is a selective, orally active monoaminergic antagonist.
More description
|
![]() |
DC77646 | Octane-1,8-diamine-Glycolic acid |
Octane-1,8-diamine-Glycolic acid is a PROTAC linker that can be used to synthesize PROTAC molecules.
More description
|
![]() |
DC77645 | OBI-992 drug-linker |
OBI-992 drug-linker is a drug-linker conjugate composed of a TOP I inhibitor Exatecan. SU14813 is a multi-targeted receptor tyrosine kinases inhibitor with IC50s of 50, 2, 4, 15 nM for VEGFR2, VEGFR1, PDGFRβ and KIT.
More description
|
![]() |
DC77644 | OA-Br-1 |
OA-Br-1 is an orally active and selective inhibitor of PTP1B with an IC50 value of 7.08 μM. OA-Br-1 induces apoptosis. OA-Br-1 has broad spectrum anti-proliferative activity against cancer cells, and plays an anti-breast cancer role through the PTP1B/PI3K/AKT signaling pathway both in vitro and in vivo.
More description
|
![]() |
DC77643 | O-2172 |
O-2172, a carbacyclic analog, is a DAT inhibitor, with IC50 values of 47 nM and 7000 nM for DAT and SERT, respectively.
More description
|
![]() |
DC77642 | NUV-244 |
NUV-244 is a PNPLA3 I148M degrader. NUV-244 reduces PNPLA3 I148M levels on lipid droplets via BFAR-mediated ubiquitin-proteasome degradation.
More description
|
![]() |
DC77641 | NSC 645827 |
NSC 645827 is an inhibitor for NAD(P)H: quinone oxidoreductase 1 (NQO1) with an IC50 of 0.7 μM.
More description
|
![]() |
DC77640 | NSC 357754 dihydrochloride |
NSC 357754 dihydrochloride is an inhibitor of Claudin. NSC 357754 dihydrochloride can increase the transepithelial electrical resistance of cells and reduce the permeability of specific cations. NSC 357754 dihydrochloride can be used in the research of intestinal diseases mediated by Claudin-2 and/or Claudin-15.
More description
|
![]() |
DC77639 | NSC 357754 |
NSC 357754 is an inhibitor of Claudin. NSC 357754 can increase the transepithelial electrical resistance of cells and reduce the permeability of specific cations. NSC 357754 can be used in the research of intestinal diseases mediated by Claudin-2 and/or Claudin-15.
More description
|
![]() |
DC77638 | Norfluoxetine oxalate |
Norfluoxetine oxalate is an active metabolite of Fluoxetine. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) class used for antidepressant research.
More description
|
![]() |
DC77637 | Nodusmicin |
Nodusmicin is a macrolide antibiotic against antibiotic-susceptible and -resistant S. aureus with MIC values of 125, 250 and 250 μg/mL for UC-76, UC-6685, and UC-6690 strains, respectively.
More description
|
![]() |
DC77635 | NHS-Modified MMAF TFA |
NHS-Modified MMAF (intermediat 210) TFA is an intermediate which can be used for producing the anti-mesothelin binder-agent conjugates (ADCs).
More description
|
![]() |
DC77634 | NH2-C2-PEG8-Succinamic acid |
NH2-C2-PEG8-Succinamic acid is a PROTAC linker. NH2-C2-PEG8-Succinamic acid can be used in synthesis TLT8.
More description
|
![]() |
DC77633 | NFh-NMe-2 |
NFh-NMe-2 is a photosensitizer, that interacts with nitroreductase, generates singlet oxygen in tumor cells, exhibits cytotoxicity in cancer cells, and induces apoptosis. NFh-NMe-2 exhibits antitumor efficacy in mouse models.
More description
|
![]() |